Rapid Nutrition Attracts Notable Investor Confidence with Swiss Investors Exercising Conversion Notices

London, United Kingdom – 29th July 2021, 8:00am CET -  Rapid Nutrition PLC (Euronext Growth: ALRPD, OTCQB: RPNRF), a natural healthcare company focused on sports nutrition, diet management and life sciences products with increasing worldwide distribution, is continuing to benefit from its focus on organic health and wellness across the globe as its cadre of Swiss investors exercise additional conversion notices. This action provides strong indication that the company’s management team is making further progress in its key strategies and outreach.

“It is heartening to see some of our largest investors further back our management team, which remains focused on enhancing shareholder value and continuing to strengthen our global presence and initiatives,” said Rapid Nutrition CEO Simon St. Ledger. “This capital increase reinforces our growth strategy while bolstering our balance sheet as we move into the second half of the year with a mind towards implementation and growth. As always, we appreciate the notable vote of confidence.”

Earlier this year, Rapid Nutrition announced that it had collectively placed convertible instruments notably with Swiss Asset Manager Alternative Gestion S.A and Nice & Green an independent Swiss investment company . This conversion will increase Rapid Nutrition’s share capital to a total number of voting rights of 43,279,811, pursuant to the entry in the commercial register. The proceeds dedicated to funding the company’s growth plans in 2021 and beyond.

The new shares will be allotted subject only to admission to listing of the new shares. Such listing is expected to take place in due course.

About Rapid Nutrition

Dedicated to the development and distribution of premium, science-based health and wellness brands across the globe, Rapid Nutrition shares a wealth of award-winning products with consumers who are passionate about innovations that are “made by nature, refined by science.” Rapid Nutrition’s first-class scientific team matches the experience of its management team to keep both the company and consumers on top of the latest industry trends and developments, while aligning with industry leaders worldwide to deliver effective supplements and solutions. Rapid Nutrition aims to be the supplier of choice globally by offering premium brands with the highest-quality ingredients to deliver maximum results.

For more information, please visit http://rnplc.com 

Investor Relations Contact:



This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and or otherwise that involve risks, uncertainties and assumptions that could cause Rapid Nutrition PLCs actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements. Rapid Nutrition PLC has in some cases identified forward-looking statements by using words such as "anticipates," "believes," "hopes," "estimates," "looks," "expects," "plans," "intends," "goal," "potential," "may," "suggest," and similar expressions. Rapid Nutrition PLC undertakes no obligation to release publicly the results of any revisions to any such forward-looking statements that may be made to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events, except as required by applicable law or regulation.

This media information does not constitute an offer to sell, or a solicitation of an offer to buy, any securities. This information does not constitute an offering prospectus within the meaning within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 of June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71 or a listing prospectus within the meaning of the listing rules of the Euronext Exchange or OTC Markets. The media release is in accordance with International Reporting Standard: Rule 12g3-2(b) under the Securities Exchange Act ('Rule 12g3-2(b)') permits non-U.S. companies with securities listed primarily on a Qualified Foreign Exchange to make publicly available to U.S investors in English the same information that is made publicly available in their home countries as an alternative to SEC reporting Exchange Act Rule 12g3-2(b).

Subscribe for Updates